NEUROSTAT

LIVE

Serial Number

85555773

Owner

PHARMING INTELLECTUAL PROPERTY B.V.

Attorney

Michael B. Chesal

Filing Date

Feb 29, 2012

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

NEUROSTAT Trademark

Serial Number: 85555773 • Registration: 4347704

NEUROSTAT is a trademark filed by PHARMING INTELLECTUAL PROPERTY B.V. on February 29, 2012. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

PHARMING INTELLECTUAL PROPERTY B.V.

DARWINWEG 24
LEIDEN 2333 CR , NL

Entity Type: 26

ABLIVA AB

MEDICON VILLAGE
LUND 22381 , SE

Entity Type: 03

NeuroVive Pharmaceutical AB (5 trademarks)

Medicon Village

Entity Type: 99

Legal Representation

Attorney of Record

Michael B. Chesal

7,421 trademarks filed View all →

Correspondence Address

Michael B. Chesal Peretz Chesal & Herrmann, P.L.

1 S.E. 3rd Avenue, Suite 1820

SunTrust International Center

Miami, FL 33131

United States

Trademark Details

Filing Date

February 29, 2012

Registration Date

June 4, 2013

Published for Opposition

July 17, 2012

Goods & Services

Pharmaceutical preparations for medical use consisting of a cyclosporin as active agent and diluents to treat stroke, traumatic brain or spinal cord injury, and other acute or chronic neurological and neurosurgical conditions

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Apr 1, 2026 ASGN

TEAS SECTION 7 REQUEST RECEIVED

Mar 29, 2026 ES7R

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Nov 14, 2023 NA89

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

Nov 14, 2023 RNL1

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

Nov 14, 2023 89AG

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Nov 8, 2023 APRE

TEAS SECTION 8 & 9 RECEIVED

May 15, 2023 E89R

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Apr 26, 2023 ASGN

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Jun 4, 2022 REM2

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

Dec 18, 2019 NAS8

REGISTERED - SEC. 8 (6-YR) ACCEPTED

Dec 18, 2019 8.OK

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

Dec 6, 2019 EROP

POST REGISTRATION ACTION MAILED - SEC. 8

Jun 14, 2019 PRA8

POST REGISTRATION ACTION CORRECTION

Jun 14, 2019 XXXX

POST REGISTRATION ACTION MAILED - SEC. 8

Jun 13, 2019 PRA8

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Jun 12, 2019 APRE

TEAS SECTION 8 RECEIVED

Jun 3, 2019 ES8R

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Jun 4, 2018 REM1

REGISTERED-PRINCIPAL REGISTER

Jun 4, 2013 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Apr 30, 2013 SUNA

LAW OFFICE REGISTRATION REVIEW COMPLETED

Apr 27, 2013 REGV

ASSIGNED TO LIE

Apr 26, 2013 ALIE

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Apr 15, 2013 CNPR

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 29, 2013 EXRA

STATEMENT OF USE PROCESSING COMPLETE

Mar 28, 2013 SUPC

SOU EXTENSION 1 GRANTED

Mar 28, 2013 EX1G

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Mar 27, 2013 AITU

USE AMENDMENT FILED

Mar 11, 2013 IUAF

SOU EXTENSION 1 FILED

Mar 11, 2013 EXT1

SOU TEAS EXTENSION RECEIVED

Mar 11, 2013 EEXT

TEAS STATEMENT OF USE RECEIVED

Mar 11, 2013 EISU

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Sep 11, 2012 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 17, 2012 NPUB

PUBLISHED FOR OPPOSITION

Jul 17, 2012 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 27, 2012 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Jun 11, 2012 CNSA

ASSIGNED TO EXAMINER

Jun 11, 2012 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 7, 2012 NWOS

NEW APPLICATION ENTERED

Mar 3, 2012 NWAP

Related Trademarks

More from this Owner

NP NEUROVIVE PHARMACEUTICAL

NEUROVIVE

NP NEUROVIVE PHARMACEUTICAL

More in Same Class

Serial #85556067